Skip to main content
. 2020 Mar 10;10:4462. doi: 10.1038/s41598-020-60563-9

Figure 7.

Figure 7

(a) Interferon protein signature (IFNPS) over time in patients who received placebo or anifrolumab 300 mg in the MUSE study. Box and whiskers represent patient quartiles. (b) Mean change from baseline in interferon protein signature over time. Error bars represent standard error of the mean (SEM). *p < 0.05 by Mann-Whitney U test. HD = healthy donors, n.s. = not significant.